Patent · US Active

Chimeric Newcastle disease viruses and uses thereof

US9217136B2 · kind B2 · utility

6Cited by

17References

14Claims

0Family size

Assignees

ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · US
Memorial Sloan Kettering Cancer Center · US

Inventors

Peter Palese · Leonia, US
Adolfo Garcia-Sastre · New York, US
Dmitriy Zamarin · New York, US
Yuman Fong · Duarte, US

Key dates

Filing date	Oct 22, 2013
Grant date	Dec 22, 2015
Priority date	—
Expiry date	Dec 16, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2760/18171
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described herein are chimeric Newcastle disease viruses engineered to express a heterologous interferon antagonist and compositions comprising such viruses. The chimeric Newcastle disease viruses and compositions are useful in the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.